Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA Management Board: highlights of October 2023 meeting 6 October 2023NewsCorporate Revised transparency rules for the EU Clinical Trials Information System (CTIS) 6 October 2023News EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 October 2023NewsHumanMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 September 2023NewsHumanPharmacovigilanceReferrals EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 September 2023NewsHumanMedicines Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 September 2023NewsHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 September 2023NewsHumanCOVID-19MedicinesReferrals Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 September 2023NewsHumanCOVID-19Medicines PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 September 2023NewsHumanReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 September 2023NewsHumanPharmacovigilanceReferrals 1 … 23 24 25 26 27 Page 27 of 380 28 29 30 31 … 380
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 October 2023NewsHumanMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 September 2023NewsHumanPharmacovigilanceReferrals
EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 September 2023NewsHumanMedicines
Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 September 2023NewsHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 September 2023NewsHumanCOVID-19MedicinesReferrals
Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 September 2023NewsHumanCOVID-19Medicines
PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 September 2023NewsHumanReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 September 2023NewsHumanPharmacovigilanceReferrals